Found: 6
Select item for more details and to access through your institution.
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26993-3
- By:
- Publication type:
- Article
DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.
- Published in:
- Oncogene, 2003, v. 22, n. 3, p. 445, doi. 10.1038/sj.onc.1206064
- By:
- Publication type:
- Article
DLC-1: a Rho GTPase-activating protein and tumour suppressor.
- Published in:
- Journal of Cellular & Molecular Medicine, 2007, v. 11, n. 5, p. 1185, doi. 10.1111/j.1582-4934.2007.00098.x
- By:
- Publication type:
- Article
Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications.
- Published in:
- Oncology Letters, 2016, v. 12, n. 2, p. 1591, doi. 10.3892/ol.2016.4781
- By:
- Publication type:
- Article
DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development
- Published in:
- FEBS Letters, 2005, v. 579, n. 5, p. 1191, doi. 10.1016/j.febslet.2004.12.090
- By:
- Publication type:
- Article
Biological functions of entactin.
- Published in:
- Kidney International, 1993, v. 43, n. 1, p. 13, doi. 10.1038/ki.1993.4
- By:
- Publication type:
- Article